| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/09/2008 | CN101214324A Chinese medicine prescription for treating chronic granulocytic leukemia patients and preparation |
| 07/09/2008 | CN101214320A Medicament for treating leukemia and preparation thereof |
| 07/09/2008 | CN101214310A Externally-applied Chinese medicine liniment for resisting cancer and relieving pain |
| 07/09/2008 | CN101214270A Acanthopanax senticosus effective fraction extract, preparation and application thereof |
| 07/09/2008 | CN101214265A Chinese cephalosporin cordyceps sinensis mixed powder and preparation method |
| 07/09/2008 | CN101214262A American cockroaches effective fraction for anti-tumor prepared by macroporous adsorption resin and use |
| 07/09/2008 | CN101214261A Medicament for mainly treating leukemia and preparation thereof |
| 07/09/2008 | CN101214260A Medicament for treating leukemia and preparation thereof |
| 07/09/2008 | CN101214238A Application of í«niuzhangzhií» extract for inhibiting tumor cell growth |
| 07/09/2008 | CN101214236A Soybean isoflavone micropills and preparation thereof |
| 07/09/2008 | CN101214234A Application of alpha-hydroxy-acid in preparing cancer and tumor in vivo injection therapeutic medicine |
| 07/09/2008 | CN101214233A Application of sodium iodoacetate in preparing medicament for treating malignant tumor |
| 07/09/2008 | CN101214232A Lutein micropills and preparation thereof |
| 07/09/2008 | CN101214231A Lycopene micropills and preparation thereof |
| 07/09/2008 | CN101214225A Resveratrol nano emulsion anti-cancer medicine |
| 07/09/2008 | CN101214224A Recombination human interferon injection |
| 07/09/2008 | CN101214220A Sustained-release injection containing amethopterin synergist |
| 07/09/2008 | CN100400659C Component of bromelain |
| 07/09/2008 | CN100400658C New type human death resist protein, its coded sequence and use |
| 07/09/2008 | CN100400657C Phosphokinase and the usage thereof |
| 07/09/2008 | CN100400645C Combination of probiotics |
| 07/09/2008 | CN100400547C Human monoclonal antibodies to prostate specific membrane antigen |
| 07/09/2008 | CN100400518C Phthalazinone derivatives |
| 07/09/2008 | CN100400107C Drugs for diagnosis of tissue-reproductive activity or treatment of proliferative disease |
| 07/09/2008 | CN100400100C Methods for preventing or attenuating patthoangiogenic conditions |
| 07/09/2008 | CN100400098C Medicine composition containing octreotide grains |
| 07/09/2008 | CN100400046C Remedies for lung cancer |
| 07/09/2008 | CN100400041C Diaminothiazoles used as CDK4 inhibitors |
| 07/09/2008 | CN100400039C Composition for treating tumours and its use |
| 07/08/2008 | US7396953 Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof |
| 07/08/2008 | US7396944 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 07/08/2008 | US7396920 Tumour suppressor and uses thereof |
| 07/08/2008 | US7396915 Specifically recognizing cancer cells such as non-small cell lung cancer, pancreatic cancer and gastric cancer cells; diagnosis and therapy |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396841 Injections |
| 07/08/2008 | US7396837 topoisomerase I inhibitors; stimulate topoisomerase I-mediated DNA cleavage and their cytotoxic potential; antitumor agent; prostate gland, ovaries, colon cancer; marine alkaloids |
| 07/08/2008 | US7396832 Inhibitors of Akt activity |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396818 Sulfotransferase inhibitor |
| 07/08/2008 | US7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
| 07/08/2008 | US7396681 Inducing an immune response by natural killer cells to increase cytolytic activity or stimulate cell proliferation by administering in or ex vivo a specific chaperone protein; treating cancerous, infectious and autoimmune diseases |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2675451A1 Combination therapy with angiogenesis inhibitors |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2436536C Methods for inducing apoptosis and inhibiting proliferation in cancer cells |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2402364C Process for producing camptothecin |
| 07/08/2008 | CA2395077C Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/08/2008 | CA2384184C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
| 07/08/2008 | CA2360754C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 07/08/2008 | CA2339384C Improved method for targeted topical treatment of disease |
| 07/08/2008 | CA2330719C Synergistic compositions comprising an ascorbate and lysine for states related to extra cellular matrix degeneration |
| 07/08/2008 | CA2308124C Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/08/2008 | CA2298681C Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 07/08/2008 | CA2253593C Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) |
| 07/08/2008 | CA2250712C Chimeric isoprenoid synthases and uses thereof |
| 07/08/2008 | CA2243948C Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 07/08/2008 | CA2218884C Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 07/08/2008 | CA2188029C Porphocyanine and cnc-expanded porphyrins |
| 07/08/2008 | CA2132836C Immunization by inoculation of dna transcription unit |
| 07/08/2008 | CA1341576C Diagnosis of retinoblastoma |
| 07/03/2008 | WO2008080134A2 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors |
| 07/03/2008 | WO2008080064A1 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders |
| 07/03/2008 | WO2008080056A2 Pyridazinones and furan-containing compounds |
| 07/03/2008 | WO2008080015A2 Compounds and methods for kinase modulation, and indications therefor |
| 07/03/2008 | WO2008080001A2 Compounds and methods for kinase modulation, and indications therefor |
| 07/03/2008 | WO2008079968A1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer |
| 07/03/2008 | WO2008079965A1 Substituted heterocycles as janus kinase inhibitors |
| 07/03/2008 | WO2008079933A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| 07/03/2008 | WO2008079918A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 07/03/2008 | WO2008079909A1 Pyrrolo [2,3-b] pyridines as kinase modulators |
| 07/03/2008 | WO2008079906A1 Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators |
| 07/03/2008 | WO2008079903A1 Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators |
| 07/03/2008 | WO2008079849A2 Antibodies to insulin-like growth factor receptor |
| 07/03/2008 | WO2008079814A2 Mapk/erk kinase inhibitors |
| 07/03/2008 | WO2008079735A1 Imidazopyridine inhibitors of iap |
| 07/03/2008 | WO2008079687A1 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 07/03/2008 | WO2008079657A1 Antitumorigenic drug combination |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008079293A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | WO2008079292A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer |
| 07/03/2008 | WO2008079277A1 Certain pyrazoline derivatives with kinase inhibitory activity |
| 07/03/2008 | WO2008079240A1 Use of liposome-entrapped agents for treating tumors |
| 07/03/2008 | WO2008079030A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 07/03/2008 | WO2008078837A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 07/03/2008 | WO2008078785A1 Klf5 suppressor and method for selecting active ingredient of the medicament |
| 07/03/2008 | WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy |
| 07/03/2008 | WO2008078362A1 Antitumor agent and food containing the same |
| 07/03/2008 | WO2008078100A2 Tricyclic amine derivatives as protein tyrosine kinase inhibitors |
| 07/03/2008 | WO2008078091A1 Bicyclic heterocyclic compounds as fgfr inhibitors |
| 07/03/2008 | WO2008078086A1 Combination of an mek inhibitor and the src kinase inhibitor azd0530 for use in the treatment of cancer |
| 07/03/2008 | WO2008078085A1 Method |
| 07/03/2008 | WO2008077885A2 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer |
| 07/03/2008 | WO2008077646A1 Non-steroidal progesterone receptor modulators |
| 07/03/2008 | WO2008077639A1 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 07/03/2008 | WO2008077618A1 Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases |
| 07/03/2008 | WO2008077548A1 Pyrimidyl derivatives as protein kinase inhibitors |
| 07/03/2008 | WO2008077546A1 Antibodies against insulin-like growth factor i receptor and uses thereof |